Regeneron Pharmaceuticals, Inc. vs Northrop Grumman Corporation
Market cap comparison over time
Regeneron Pharmaceuticals, Inc.
$80.6B
Rank #200
Northrop Grumman Corporation
$81.8B
Rank #196
Market Cap Over Time
Key Moments
- Regeneron Pharmaceuticals, Inc. overtook Northrop Grumman Corporation by 2000
- Northrop Grumman Corporation overtook Regeneron Pharmaceuticals, Inc. by 2001
- Regeneron Pharmaceuticals, Inc. overtook Northrop Grumman Corporation by 2012
- Northrop Grumman Corporation overtook Regeneron Pharmaceuticals, Inc. by 2019
- Regeneron Pharmaceuticals, Inc. overtook Northrop Grumman Corporation by 2020
- Northrop Grumman Corporation overtook Regeneron Pharmaceuticals, Inc. by 2025
Year-by-Year Comparison
| Year | Regeneron Pharmaceuticals, Inc. | Northrop Grumman Corporation | Leader |
|---|---|---|---|
| 2026 | $80.6B | $81.8B | Northrop Grumman Corporation |
| 2025 | $79.3B | $80.1B | Northrop Grumman Corporation |
| 2024 | $72.8B | $64.7B | Regeneron Pharmaceuticals, Inc. |
| 2023 | $89.7B | $63.8B | Regeneron Pharmaceuticals, Inc. |
| 2022 | $73.7B | $73.1B | Regeneron Pharmaceuticals, Inc. |
| 2021 | $64.5B | $51.1B | Regeneron Pharmaceuticals, Inc. |
| 2020 | $49.4B | $39.6B | Regeneron Pharmaceuticals, Inc. |
| 2019 | $38.4B | $43.9B | Northrop Grumman Corporation |
| 2018 | $38.2B | $30.8B | Regeneron Pharmaceuticals, Inc. |
| 2017 | $38.4B | $37.8B | Regeneron Pharmaceuticals, Inc. |
| 2016 | $37.5B | $28.3B | Regeneron Pharmaceuticals, Inc. |
| 2015 | $55.5B | $22.7B | Regeneron Pharmaceuticals, Inc. |
| 2014 | $41.9B | $17.4B | Regeneron Pharmaceuticals, Inc. |
| 2013 | $28.1B | $13.2B | Regeneron Pharmaceuticals, Inc. |
| 2012 | $17.5B | $7.6B | Regeneron Pharmaceuticals, Inc. |
| 2011 | $5.7B | $6.3B | Northrop Grumman Corporation |
| 2010 | $3.4B | $6.1B | Northrop Grumman Corporation |
| 2009 | $2.5B | $5.1B | Northrop Grumman Corporation |
| 2008 | $1.9B | $4.0B | Northrop Grumman Corporation |
| 2007 | $2.5B | $6.8B | Northrop Grumman Corporation |
| 2006 | $2.1B | $5.7B | Northrop Grumman Corporation |
| 2005 | $1.6B | $5.0B | Northrop Grumman Corporation |
| 2004 | $941.1M | $4.4B | Northrop Grumman Corporation |
| 2003 | $1.5B | $3.8B | Northrop Grumman Corporation |
| 2002 | $1.9B | $3.8B | Northrop Grumman Corporation |
| 2001 | $2.9B | $3.9B | Northrop Grumman Corporation |
| 2000 | $3.6B | $3.2B | Regeneron Pharmaceuticals, Inc. |
| 1999 | $1.3B | $2.0B | Northrop Grumman Corporation |
| 1998 | $753.6M | $2.7B | Northrop Grumman Corporation |
| 1997 | $874.9M | $4.1B | Northrop Grumman Corporation |
| 1996 | $1.6B | $2.9B | Northrop Grumman Corporation |
| 1995 | $1.3B | $2.2B | Northrop Grumman Corporation |
| 1994 | $306.5M | $1.4B | Northrop Grumman Corporation |